Current cancer drug targets影响因子
WebHyun-Jin An, Mi-Gyeong Gwon, Hyemin Gu, Seongjae Bae, Jaechan Leem, Jin Bae Lee, Kwan-Kyu Park. Article Number: 37 Published online on: 31 March 2024. Web期刊名称. CURR PROB CANCER/CURRENT PROBLEMS IN CANCER. ISSN. 0147-0272. 影响指数话题. 影响指数话题. 预警等级. MedSci期刊指数. 6.769 （MedSci实时期刊指数） 5.25578 （5年期刊指数）.
Current cancer drug targets影响因子
Did you know?
WebCarcinogenesis is a peer-reviewed medical journal in the field of cancer biology. It was established in 1980 and is published monthly by Oxford University Press. As of 2010, the editor-in-chief is Curtis C. Harris (National Cancer Institute). Carcinogenesis publishes articles in four sections: cancer biology covers the cell and molecular ... WebCurrent Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and …
WebCurrent Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of …
WebCURRENT CANCER DRUG TARGETS. 出版年份：2001 年文章数：29 投稿命中率：43.75%. 出版周期：Monthly 自引率：1.2% 审稿周期：平均2.4月. 前往期刊查询. 期刊 … WebCURRENT CANCER DRUG TARGETS. 出版年份：2001 年文章数：29 投稿命中率：43.75%. 出版周期：Monthly 自引率：1.2% 审稿周期：平均2.4月. 前往期刊查询. 期刊 …
WebCurrent Topics in Medicinal Chemistry is a biweekly peer-reviewed medical journal published by Bentham Science Publishers. It includes review articles on all aspects of medicinal chemistry, including drug design. The editor-in-chief is Allen B. Reitz (Fox Chase Chemical Diversity Center).
WebApr 10, 2024 · Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new … how to revert two commitsWebAims & Scope. Current Cancer Drug Targets aims to cover all the latest and outstanding developments in full spectrum of cancer drug discovery and development, including but not limited to cellular and molecular biology, genomics, proteomics, metabolomics, medicinal chemistry, pharmacology, toxicology, and biochemistry of contemporary molecular drug … north el pasoWebApr 8, 2024 · 《journal of drug targeting》发布于爱科学网，并永久归类相关sci期刊导航类别中，本站只是硬性分析 "《j drug target》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。"《j drug target》" 的价值还取决于各种因素 … how to revert version hoi4http://www.scizj.com/sci/14188.html north elston ave chicagoWebApr 5, 2024 · Expert Opinion on Therapeutic Targets (ISSN 1472-8222 [print], 1744-7631 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on novel molecular targets, providing expert opinion on the scope for future drug development and the impact on drug discovery.. The journal … northelp.onmicrosoft.comWebCurrent Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth … northel septiproWebMolecular Pharmaceutics is a Transformative Journal. Molecular Pharmaceutics has been certified as a transformative journal by cOAlition S, committing to a transition to 100% open access in the future. If your research funder has signed Plan S, your open access charges may be covered by your funder through December 31, 2024. how to revert win 11 to 10